Tert-Butyl nitrite → N-(6-cyclopropyl-5-(6-(3,5-dimethylisoxazol-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-4-yl)pyridin-3-yl)acetamide
Reaction equation
[NH2:1][C:2]1[CH:3]=[C:4]([C:11]2[C:19]3[NH:18][C:17](=[O:20])[NH:16][C:15]=3[CH:14]=[C:13]([C:21]3[C:22]([CH3:27])=[N:23][O:24][C:25]=3[CH3:26])[CH:12]=2)[C:5]([CH:8]2[CH2:10][CH2:9]2)=[N:6][CH:7]=1.N([O:30][C:31](C)(C)[CH3:32])=O>C(#N)C.CCOC(C)=O>[CH:8]1([C:5]2[N:6]=[CH:7][C:2]([NH:1][C:31](=[O:30])[CH3:32])=[CH:3][C:4]=2[C:11]2[C:19]3[NH:18][C:17](=[O:20])[NH:16][C:15]=3[CH:14]=[C:13]([C:21]3[C:22]([CH3:27])=[N:23][O:24][C:25]=3[CH3:26])[CH:12]=2)[CH2:9][CH2:10]1Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
4-(5-Amino-2-cyclopropylpyridin-3-yl)-6-(3,5-dimethylisoxazol-4-yl)-1H-benzo[d]imidazol-2(3H)-one (75 mg, 0.21 mmol) was dissolved in acetonitrile (2 mL), at room temperature added tert-butyl nitrite (32 mg, 0.31 mmol) and CuBr2 (56 mg, 0.25 mmol), stirred at room temperature for 1 h. The reaction mixture was diluted with EtOAc, washed with brine, evaporated organic solvent, purified with Prep HPLC. (0-100% CH3CN/H2O) to afford 16 mg of N-(6-cyclopropyl-5-(6-(3,5-dimethylisoxazol-4-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-4-yl)pyridin-3-yl)acetamide.
Workup
- washwashed with brine
- customevaporated organic solvent
- custompurified with Prep HPLC
Sources & evidence
- ORD record
- ord-dce4709c61fa4f9e93cc0ebd0fe5ef14
- Source dataset
- uspto-grants-2016_02
- Patent number
- US09255089B2
Reaction notes
Loading…